Role of lncRNAs in prostate cancer development and progression

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Prostate cancer (PCa) remains a leading cause of cancer-related deaths in men.
• The precise etiology of PCa is not fully understood despite advances in genomic and epigenetic research.
• Long non-coding RNAs (lncRNAs) have emerged as key regulators of gene expression, particularly through epigenetic mechanisms.

Purpose of the Study:

• To summarize current knowledge on the roles of lncRNAs in prostate cancer.
• To highlight the potential of lncRNAs as biomarkers for aggressive PCa.
• To explore lncRNAs as novel therapeutic targets in PCa.

Main Methods:

• Review of accumulated evidence on lncRNA dysregulation in PCa.
• Analysis of functional studies implicating lncRNAs in prostate carcinogenesis.
• Examination of lncRNA targeting of key signaling pathways and epigenetic mechanisms.

Main Results:

• Hundreds of lncRNAs are dysregulated in prostate cancer.
• lncRNAs contribute to PCa by targeting pathways like PTEN/AKT and androgen receptor signaling.
• lncRNAs are involved in chromatin remodeling complexes relevant to PCa.

Conclusions:

• lncRNAs play significant roles in the development and progression of prostate cancer.
• Dysregulated lncRNAs show promise as diagnostic and prognostic biomarkers for aggressive PCa.
• Targeting lncRNAs represents a potential novel therapeutic strategy for prostate cancer treatment.